ArticleJournal of clinical and experimental dentistry2024
Antibacterial effect of resveratrol extract compared to chlorhexidine mouthwash against primary cariogenic pathogen, Streptococcus mutans.
Article in Journal of clinical and experimental dentistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- In Vitro Antibacterial and Antibiofilm Effects of Antiseptics and Mouthwashes onPathogens (Basel, Switzerland) · 2026Article
- Evaluation of Physicochemical and Mechanical Properties of a Modified Adhesive System by Resveratrol Incorporation.Journal of functional biomaterials · 2025Article
- Natural compounds: new therapeutic approach for inhibition ofFrontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Modern dental caries prevention methods have focused on using herbal products that ideally inhibit the critical cariogenic bacteria ( Material and Methods: In this Results: The MIC and MBC of resveratrol was 250 µg/mL. In addition, this extract exhibited a diameter of 6.67 mm for the inhibition zone at only the 1000-µg/mL concentration. The MIC of CHX was 15.6 µg/mL, and its MBC was 31.25 µg/mL. The highest growth inhibition zone of CHX was 16.67 mm. Conclusions: Resveratrol extract exhibited a dose-dependent antibacterial (bacteriostatic and bactericidal) activity against
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.